GOVX Intrinsic Valuation and Fundamental Analysis - GeoVax Labs Inc

	GeoVax Labs Inc NASDAQ:GOVX	US
I	IPG Photonics Corp F:IPF	US
	Findi Ltd ASX:FND	AU
	Scully Royalty Ltd F:MB01	CN

Intrinsic Value

Is GOVX undervalued or overvalued?

See the intrinsic value estimate for GeoVax Labs Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

GOVX Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with GOVX’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price $0.19

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What GeoVax Labs Does

Biotechnology Health Care

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is headquartered in Smyrna, Georgia and currently employs 19 full-time employees. Its lead clinical program is GEO-CM04S1, a COVID-19 vaccine, which is in three phase II clinical trials, being evaluated as a primary vaccine for immunocompromised patients, such as those suffering from hematologic cancers and other patient populations for whom the current authorized…

Headquarters: United States of America US
Employees: 17
IPO date: Apr 4, 1994